Answers are grounded in this paper and cite their sources.
This case represents a possible novel approach to reducing resistance in patients harboring this rare EGFR mutation which may translate to better outcomes.
No takes yet. Share an insight, caveat, or question.
Messeha et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: